Opgen Stock Price, News & Analysis
Company Description
Opgen (OTC Link: CFOR) is a publicly traded capital markets company in the Financial Services sector. The company has a market capitalization of $243.5M.
CFOR stock has gained 58.3% over the past year. Shares last traded at $23.75.
On a trailing twelve-month basis, Opgen reported revenue of $5.2M with net income of $12.0M and diluted earnings per share of $2.30. The company operates at a net profit margin of 230.8%.
This page provides a comprehensive overview of CFOR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Opgen (CFOR) stock last traded at $23.75, down 6.99% from the previous close. Over the past 12 months, the stock has gained 58.3%. At a market capitalization of $243.5M, CFOR is classified as a micro-cap stock with approximately 10.2M shares outstanding.
Latest News
SEC Filings
Opgen has filed 1 recent SEC filing, including 1 Form NT 10-K. The most recent filing was submitted on March 31, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CFOR SEC filings →
Financial Highlights
Opgen generated $5.2M in revenue over the trailing twelve months, operating income reached $325K (6.3% operating margin), and net income was $12.0M, reflecting a 230.8% net profit margin. Diluted earnings per share stood at $2.30. The company generated -$4.9M in operating cash flow. With a current ratio of 4.18, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Days to Cover History
CFOR Company Profile & Sector Positioning
Opgen (CFOR) operates in the Capital Markets industry within the broader Financial Services sector and is listed on the OTC Link.